Inthera Bioscience's Seed VC Round

Inthera Bioscience raised a round of funding on December 15, 2015.

Inthera Bioscience, founded in 2013, employs a proprietary technology platform to rationally design protein-protein interaction inhibitors. The company has discovered disruptors of hypoxia-inducible s…

Articles about Inthera Bioscience's Seed VC Round: